UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF
THE SECURITIES EXCHANGE ACT OF 1934
LEAP THERAPEUTICS, INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware |
|
2834 |
|
27-4412575 |
(State of Incorporation) |
|
(Primary Standard Industrial |
|
(IRS Employer |
47 Thorndike Street
Suite B1-1
Cambridge, MA 02141
Telephone: (617) 252-4343
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Name of each exchange on which |
Common Stock, par value $0.001 per share |
|
The NASDAQ Stock Market LLC |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. o
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. o
If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. o
Securities Act registration statement file number to which this form relates: (if applicable)
Securities to be registered pursuant to Section 12(g) of the Act: None
INFORMATION REQUIRED IN REGISTRATION STATEMENT
ITEM 1 DESCRIPTION OF REGISTRANTS SECURITIES TO BE REGISTERED
Leap Therapeutics, Inc., a Delaware corporation (the Registrant), hereby incorporates by reference herein the description of its common stock, par value $0.001 per share, to be registered hereunder, set forth under the heading Description of Leap Capital Stock in the Registrants prospectus forming part of its Registration Statement on Form S-4 (File No. 333-333-213794), originally filed with the Securities and Exchange Commission (the Commission) pursuant to the Securities Act of 1933, as amended (the Securities Act), on September 26, 2016, as thereafter amended and supplemented (the Registration Statement).
ITEM 2 EXHIBITS
Pursuant to the Instructions as to Exhibits for this registration statement on Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, hereunto duly authorized.
|
| |
|
LEAP THERAPEUTICS, INC. | |
|
|
|
Date: January 20, 2017 |
By: |
/s/ Christopher K. Mirabelli |
|
Name: |
Christopher K. Mirabelli |
|
Title: |
Chief Executive Officer |